Vivos Therapeutics, Inc.
VVOS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716166
No open-market purchases or sales by Vivos Therapeutics, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $242.7K in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Vivos Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −1 vs. Q1 2025
- Shares held
- 402.1K
- +53.3K (+15.3%) vs. Q1 2025
- Total value
- $1.27M
- +$277.3K (+27.9%) vs. Q1 2025
- New holders
- 4
- 5 more added
- Sold out
- 5
- 2 more reduced
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VVOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $242.7K |
| Q1 2026 | 25 | $2.15M |
| Q4 2025 | 20 | $1.34M |
| Q3 2025 | 23 | $2.13M |
| Q2 2025 | 19 | $1.27M |
| Q1 2025 | 21 | $1.00M |
| Q4 2024 | 20 | $2.00M |
| Q3 2024 | 23 | $630.7K |
| Q2 2024 | 19 | $433.8K |
| Q1 2024 | 16 | $646.8K |
| Q4 2023 | 18 | $3.12M |
| Q3 2023 | 28 | $860.6K |
| Q2 2023 | 31 | $2.39M |
| Q1 2023 | 30 | $1.71M |
| Q4 2022 | 27 | $629.7K |
| Q3 2022 | 30 | $1.38M |
| Q2 2022 | 28 | $2.82M |
| Q1 2022 | 28 | $6.66M |
| Q4 2021 | 29 | $5.02M |
| Q3 2021 | 37 | $9.14M |
| Q2 2021 | 29 | $11.7M |
| Q1 2021 | 18 | $5.45M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Vivos Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 142,801 | $451.3K | 0.00% | +140,922+7,499.8% | Added |
| National Asset Management, Inc. | 69,531 | $219.7K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 57,902 | $183.0K | 0.00% | +553+1.0% | Added |
| Vanguard Group Inc | 42,634 | $134.7K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 41,000 | $130.0K | 0.00% | +7,000+20.6% | Added |
| XTX Topco Ltd | 20,528 | $64.9K | 0.00% | +20,528 | New |
| Northern Trust Corp | 12,511 | $39.5K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 11,822 | $37.4K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,065 | $3.37K | 0.00% | −249−18.9% | Reduced |
| Advisor Group Holdings, Inc. | 793 | $2.50K | 0.00% | +593+296.5% | Added |
| Signaturefd, LLC | 547 | $1.73K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 497 | $1.57K | 0.00% | +497 | New |
| Ronald Blue Trust, Inc. | 160 | $506 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 137 | $433 | 0.00% | +7+5.4% | Added |
| Kozak & Associates, Inc. | 49 | $294 | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Inc | 74 | $234 | 0.00% | +74 | New |
| Global Retirement Partners, LLC | 23 | $73 | 0.00% | +23 | New |
| Steward Partners Investment Advisory, LLC | 8 | $25 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 4 | $0 | 0.00% | −18,000−100.0% | Reduced |
| Cutter & CO Brokerage, Inc. | 0 | $0 | 0.00% | −49,100−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −38,873−100.0% | Sold out |
| Ewa, LLC | 0 | $0 | 0.00% | −10,464−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −228−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Credit Agricole S A | – | – | – | – | Not filed |